Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 8.90B | 7.02B | 6.10B | 5.23B | 4.36B | 3.72B |
Gross Profit | 6.17B | 4.10B | 3.61B | 2.85B | 2.25B | 2.10B |
EBITDA | 3.42B | 3.38B | 3.01B | 2.55B | 2.03B | 1.89B |
Net Income | 2.47B | 1.95B | 1.72B | 1.49B | 1.21B | 1.08B |
Balance Sheet | ||||||
Total Assets | 222.06B | 222.40B | 237.73B | 269.11B | 222.92B | 152.77B |
Cash, Cash Equivalents and Short-Term Investments | 117.00B | 130.41B | 140.50B | 138.23B | 110.97B | 90.94B |
Total Debt | 7.19B | 9.58B | 8.72B | 5.36B | 6.32B | 4.80B |
Total Liabilities | 210.39B | 210.85B | 227.63B | 260.05B | 215.18B | 146.21B |
Stockholders Equity | 11.16B | 10.77B | 9.66B | 8.47B | 7.19B | 6.17B |
Cash Flow | ||||||
Free Cash Flow | 1.15B | 2.05B | 2.28B | 2.16B | 702.50M | 1.22B |
Operating Cash Flow | 1.31B | 2.41B | 2.55B | 2.48B | 908.90M | 1.41B |
Investing Cash Flow | 243.30M | -60.00M | -4.00B | -1.41B | -2.17B | -787.70M |
Financing Cash Flow | -1.11B | -1.35B | 2.29B | -951.10M | 798.70M | -254.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | €3.07B | 23.18 | 15.62% | 0.14% | 16.59% | 17.56% | |
70 Outperform | €46.98B | 23.92 | 19.61% | 1.55% | 9.07% | 10.34% | |
65 Neutral | £5.42B | 8.81 | 9.53% | 5.11% | 10.07% | -13.05% | |
― | €224.54M | 38.30 | 7.07% | 7.32% | ― | ― | |
― | €231.93M | 4.84 | 24.12% | 2.72% | ― | ― | |
44 Neutral | €184.59M | ― | -13.03% | ― | ― | ― | |
― | €2.15B | 72.98 | 13.81% | ― | ― | ― |